Foghorn Therapeutics
Price & Volume
Stats
See moreOpen | $4.95 |
Previous Close | $4.93 |
Day Range | $4.84-$4.95 |
52W Range | $2.94-$6.95 |
Market Cap | $281.7M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $30.9M |
Revenue Growth (YoY) | 223.8% |
Gross Profit (12 Mos) | -$54.5M |
Diluted EPS | -$1.18 |
News
See moreYahoo Finance • 15 days ago
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook
Yahoo Finance • 5 months ago
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences
Yahoo Finance • 5 months ago
Foghorn Therapeutics Announces Updates for Selective ARID1B, Selective CBP and Selective EP300 Degrader Programs
About
CEO | Mr. Adrian H. B. Gottschalk |
Address | 99 Coolidge Avenue, Watertown, MA, United States, 02472 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 106 |
